AIDS Research
amfAR awards $1.2 million
Published in AIDS Weekly, April 7th, 2003
"amfAR pursues a research strategy that can be described as entrepreneurial," said Jerome J. Radwin, amfAR's CEO. "Much of this funding supports the study of viral reservoirs, where HIV may lie dormant despite years of antiretroviral therapy. These grantees and fellows will help describe viral latency, which may be the major factor preventing the eradication of HIV. Their work stands at the vanguard of current HIV research."
HIV can sequester itself in reservoirs in the body and in some cases remains...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2003-04-07)
More Articles from AIDS Weekly
- Alcoholism
Alcohol abuse may increase susceptibility to HIV infection - Immunology
Study of monkey species that fights off AIDS may lead to new treatments for humans - Critical Care Medicine
HIV Tat can be used for intracellular HSP70 delivery - HIV Mutation
Body's own antibodies may drive new strains of HIV - HIV/AIDS Opportunistic Infections
Simian Pneumocystis carinii model may aid pneumonia research - Risk Behaviors
Young gay men are anxious, depressed, and ignorant of their HIV status - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
